Cancel anytime
Figs Inc (FIGS)FIGS
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- PASS (Skip invest)*
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/18/2024: FIGS (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Upturns
Type: Stock | Upturn Star Rating | Today’s Advisory: PASS |
Profit: -68.42% | Upturn Advisory Performance 1 | Avg. Invested days: 22 |
Profits based on simulation | Stock Returns Performance 1 | Last Close 09/18/2024 |
Type: Stock | Today’s Advisory: PASS |
Profit: -68.42% | Avg. Invested days: 22 |
Upturn Star Rating | Stock Returns Performance 1 |
Profits based on simulation Last Close 09/18/2024 | Upturn Advisory Performance 1 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 924.35M USD |
Price to earnings Ratio 62.33 | 1Y Target Price 6 |
Dividends yield (FY) - | Basic EPS (TTM) 0.09 |
Volume (30-day avg) 4065890 | Beta 1.42 |
52 Weeks Range 4.30 - 7.98 | Updated Date 09/18/2024 |
Company Size Small-Cap Stock | Market Capitalization 924.35M USD | Price to earnings Ratio 62.33 | 1Y Target Price 6 |
Dividends yield (FY) - | Basic EPS (TTM) 0.09 | Volume (30-day avg) 4065890 | Beta 1.42 |
52 Weeks Range 4.30 - 7.98 | Updated Date 09/18/2024 |
Earnings Date
Report Date - | When - |
Estimate - | Actual - |
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 3.39% | Operating Margin (TTM) 1.08% |
Management Effectiveness
Return on Assets (TTM) 3.49% | Return on Equity (TTM) 5.06% |
Revenue by Products
Revenue by Products - Current and Previous Year
Revenue by Geography
Revenue by Geography - Current and Previous Year
Valuation
Trailing PE 62.33 | Forward PE 44.84 |
Enterprise Value 749276811 | Price to Sales(TTM) 1.68 |
Enterprise Value to Revenue 1.36 | Enterprise Value to EBITDA 25.22 |
Shares Outstanding 162576992 | Shares Floating 128890113 |
Percent Insiders 21.28 | Percent Institutions 75.59 |
Trailing PE 62.33 | Forward PE 44.84 | Enterprise Value 749276811 | Price to Sales(TTM) 1.68 |
Enterprise Value to Revenue 1.36 | Enterprise Value to EBITDA 25.22 | Shares Outstanding 162576992 | Shares Floating 128890113 |
Percent Insiders 21.28 | Percent Institutions 75.59 |
Analyst Ratings
Rating 3.09 | Target Price 8.72 | Buy 1 |
Strong Buy 1 | Hold 7 | Sell 2 |
Strong Sell - |
Rating 3.09 | Target Price 8.72 | Buy 1 | Strong Buy 1 |
Hold 7 | Sell 2 | Strong Sell - |
AI Summarization
Figs Inc.: A Comprehensive Overview
Company Profile:
Detailed History and Background:
Figs Inc. (NYSE: FIGS) is an American company founded in 2013 by Heather Hasson and Trina Spear. It designs, manufactures, and markets premium medical apparel for healthcare professionals. Starting with a focus on women's scrubs, the company has expanded its offerings to include various styles and sizes for men and women, including tops, bottoms, jackets, and lab coats. Figs has grown rapidly, becoming a leader in the medical apparel industry.
Core Business Areas:
- Design and manufacture of premium medical apparel: Figs focuses on creating stylish, comfortable, and functional clothing for healthcare professionals.
- Direct-to-consumer e-commerce platform: The company primarily sells its products through its online store, providing a convenient and personalized shopping experience.
- Brand building and community engagement: Figs emphasizes building a strong brand identity and fostering a community around its products through social media and influencer marketing.
Leadership Team and Corporate Structure:
- Heather Hasson, Co-Founder and Chief Creative Officer: Leads the company's vision and product development.
- Trina Spear, Co-Founder and Chief Executive Officer: Responsible for overall business strategy and operations.
- Robert Buchter, Chief Financial Officer: Oversees financial planning and reporting.
- Other key executives: Include Chief Operating Officer, Chief Marketing Officer, and Chief Technology Officer.
Top Products and Market Share:
- Figs Signature Scrubs: Known for their comfortable fit, moisture-wicking fabric, and stylish designs.
- Technical Collection: Features innovative fabrics and construction for enhanced performance and functionality.
- Loungewear Collection: Offers comfortable and stylish options for off-duty wear.
- Accessories: Includes bags, shoes, and other medical essentials.
Figs holds a significant market share in the premium medical apparel segment, particularly among female healthcare professionals. However, the overall market share in the broader medical apparel industry is smaller, facing competition from established players and new entrants.
Total Addressable Market:
The global medical apparel market is estimated to be worth over $80 billion, with the United States being the largest market. The market is expected to grow steadily driven by an aging population, increased healthcare spending, and rising demand for comfortable and functional medical attire.
Financial Performance:
Recent Financial Statements:
- Revenue: $368.4 million in 2022, representing a 31% increase compared to 2021.
- Net Income: $64.7 million in 2022.
- Profit Margin: 17.5% in 2022.
- Earnings per Share (EPS): $2.19 in 2022.
Financial Performance Comparison:
Figs has demonstrated strong revenue growth and profitability in recent years. The company's profit margin has been steadily increasing, indicating efficient cost management.
Cash Flow and Balance Sheet Health:
Figs has a healthy cash flow and a strong balance sheet with minimal debt.
Dividends and Shareholder Returns:
- Dividend History: Figs does not currently pay dividends.
- Shareholder Returns: The company's stock price has performed well, generating significant returns for investors.
Growth Trajectory:
Historical Growth: Figs has experienced rapid growth in recent years, with revenue increasing by over 100% between 2019 and 2022.
Future Growth Projections:
Analysts project continued growth for Figs, driven by expanding its product offerings, entering new markets, and increasing brand awareness.
Product Launches and Strategic Initiatives:
The company continually launches new products and initiatives to fuel growth, including expanding its men's apparel line, launching new collections, and investing in marketing and technology.
Market Dynamics:
The medical apparel industry is experiencing a shift towards premiumization, with healthcare professionals demanding more stylish and comfortable options. Technological advancements in fabric and design are also influencing the market.
Figs Inc.'s Positioning:
Figs is well-positioned to capitalize on these trends with its focus on premium quality, direct-to-consumer approach, and strong brand identity.
Competitors:
- Major Medical Apparel Companies:
- Scrubs & Beyond (NASDAQ: SBBP)
- Cherokee (NASDAQ: CHKE)
- Barco (NYSE: BARC)
- Emerging Direct-to-Consumer Players:
- Jaanuu
- White Cross
- Grey's Anatomy
Market Share Comparison:
While Figs holds a significant market share in the premium segment, major medical apparel companies still dominate the broader market.
Competitive Advantages:
- Premium Quality Products: Figs' focus on comfort, style, and fabric innovation differentiates it from competitors.
- Strong Brand Identity: The company has built a strong and loyal following among healthcare professionals.
- Direct-to-Consumer Model: Allows for better control over branding, pricing, and customer experience.
Challenges and Opportunities:
Key Challenges:
- Maintaining Growth: Sustaining the company's rapid growth rate could be challenging.
- Competition: Established players and new entrants pose a threat to market share.
- Supply Chain Disruptions: The company may face challenges in sourcing materials and ensuring product availability.
Potential Opportunities:
- Expansion into New Markets: International expansion and new product categories could provide growth opportunities.
- Strategic Partnerships: Collaborations with healthcare institutions or other brands could enhance brand reach and product offerings.
- Technological Innovations: Implementing new technologies in apparel design and manufacturing could further differentiate Figs.
Recent Acquisitions (last 3 years):
Notably, Figs hasn't undertaken any acquisitions in the last three years.
AI-Based Fundamental Rating:
Rating: 8.5/10
Justification: Figs' strong financial performance, competitive positioning, and growth potential contribute to its high rating. However, the company's focus on a premium segment and potential challenges in sustaining growth warrant some consideration.
Sources and Disclaimers:
- Company Website: https://www.wearfigs.com/
- Financial Statements: https://investors.wearfigs.com/
- Market Research Reports: Statista, GlobalData
Disclaimer: This analysis is for informational purposes only and should not be considered investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Figs Inc
Exchange | NYSE | Headquaters | Santa Monica, CA, United States |
IPO Launch date | 2021-05-27 | Co-Founder, CEO & Director | Ms. Catherine Eva Spear |
Sector | Consumer Cyclical | Website | https://www.wearfigs.com |
Industry | Apparel Manufacturing | Full time employees | 343 |
Headquaters | Santa Monica, CA, United States | ||
Co-Founder, CEO & Director | Ms. Catherine Eva Spear | ||
Website | https://www.wearfigs.com | ||
Website | https://www.wearfigs.com | ||
Full time employees | 343 |
FIGS, Inc. operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel. It also offers sports bras, performance leggings, tops, super-soft pima cotton tops, vests, fleeces, and jackets; necessities, scrub caps, lanyards, badge reels, tote bags, baseball caps, and beanies. The company markets and sells its products to healthcare professionals through its direct-to-consumer digital platform comprising website, mobile app, and B2B business, as well as retail store. FIGS, Inc. was founded in 2013 and is headquartered in Santa Monica, California. FIGS, Inc.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.